LEADER 01269nam  2200409   450 
001 9910148724503321
005 20130810075249.0
010   $a1-62257-152-5
035   $a(CKB)3710000000922296
035   $a(MiAaPQ)EBC4743828
035   $a(EXLCZ)993710000000922296
100   $a20130103h20122012  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aAuthorized generic drugs $eshort and long-term competitive effects /$fEdward R. Nelson and Jerry G. Wright, editors
210  1$aNew York :$cNova Biomedical,$d[2012]
210  4$dİ2012
215   $a1 online resource (226 pages) $cillustrations
225 1 $aPharmacology research, safety testing, and regulation
311   $a1-62257-075-8 
320   $aIncludes bibliographical references and index.
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aGeneric drugs
615  0$aGeneric drugs.
676   $a615.1
702   $aNelson$b Edward R.
702   $aWright$b Jerry G.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910148724503321
996   $aAuthorized generic drugs$92879603
997   $aUNINA